AngioDynamics, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
ANGO Nasdaq 3840 www.angiodynamics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AngioDynamics, Inc.

AngioDynamics (ANGO) Up 8.9% Since Last Earnings Report: Can It Continue? - Aug 13th, 2026 9:30 am
AngioDynamics Sees MedTech Becoming Majority of Revenue in Fiscal 2027 - Aug 11th, 2026 5:04 pm
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure? - Aug 6th, 2026 12:16 pm
ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in Focus - Aug 6th, 2026 12:13 pm
ANGO Jumps 33.5% in 3 Months: Can the Rally Keep Going? - Aug 6th, 2026 12:07 pm
AngioDynamics to Participate in Upcoming Investor Conferences - Jul 28th, 2026 6:30 am
AngioDynamics (ANGO) Q4 2026 Earnings Call Transcript - Jul 21st, 2026 1:47 pm
AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands - Jul 15th, 2026 8:29 am
AngioDynamics, Inc. Q4 2026 Earnings Call Summary - Jul 15th, 2026 6:30 am
AngioDynamics Inc (ANGO) Q4 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges - Jul 14th, 2026 1:00 pm
AngioDynamics Q4 Earnings Call Highlights - Jul 14th, 2026 7:03 am
AngioDynamics (ANGO) Reports Q4 Loss, Beats Revenue Estimates - Jul 14th, 2026 5:15 am
AngioDynamics Tops Revenue Forecasts and Raises Sales Outlook for Fiscal 2027 (ANGO) - Jul 14th, 2026 4:49 am
AngioDynamics: Fiscal Q4 Earnings Snapshot - Jul 14th, 2026 4:18 am
AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability - Jul 14th, 2026 4:00 am
AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026 - Jun 30th, 2026 6:00 am
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now - Jun 23rd, 2026 11:06 am
ANGO Gains FDA IDE Approval for NanoKnife BPH Feasibility Study - Jun 18th, 2026 7:52 am
AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH) - Jun 17th, 2026 6:30 am